Literature DB >> 17593160

Where are all those patients with Celiac disease?

Peter H R Green.   

Abstract

Celiac disease is considered to occur in approximately 1% of the U.S. population. It is, however, markedly underdiagnosed. In this issue, Fasano and his colleagues have continued their work in demonstrating just where all these patients are. Their current study explores a case finding policy in the primary practice setting. They identified patients who exhibited either symptoms that could be attributed to celiac disease, or had an associated condition. In this population, 2.25% had celiac disease. The study emphasizes the need for physician education in both the prevalence of celiac disease and the wide availability of the serological tests that can facilitate the diagnosis of celiac disease.

Entities:  

Mesh:

Year:  2007        PMID: 17593160     DOI: 10.1111/j.1572-0241.2007.01167.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  12 in total

1.  New and developing therapies for celiac disease.

Authors:  Christina A Tennyson; Suzanne K Lewis; Peter H R Green
Journal:  Therap Adv Gastroenterol       Date:  2009-09       Impact factor: 4.409

2.  Increasing Incidence and Altered Presentation in a Population-based Study of Pediatric Celiac Disease in North America.

Authors:  Eyad Almallouhi; Katherine S King; Bhavisha Patel; Chung Wi; Young J Juhn; Joseph A Murray; Imad Absah
Journal:  J Pediatr Gastroenterol Nutr       Date:  2017-10       Impact factor: 2.839

Review 3.  Coeliac disease and the videocapsule: what have we learned till now.

Authors:  Edward J Ciaccio; Suzanne K Lewis; Govind Bhagat; Peter H Green
Journal:  Ann Transl Med       Date:  2017-05

4.  Sensitization to gliadin induces moderate enteropathy and insulitis in nonobese diabetic-DQ8 mice.

Authors:  Heather J Galipeau; Nestor E Rulli; Jennifer Jury; Xianxi Huang; Romina Araya; Joseph A Murray; Chella S David; Fernando G Chirdo; Kathy D McCoy; Elena F Verdu
Journal:  J Immunol       Date:  2011-09-12       Impact factor: 5.422

5.  Performance of serology assays for diagnosing celiac disease in a clinical setting.

Authors:  Miriam Parizade; Yoram Bujanover; Batya Weiss; Vered Nachmias; Bracha Shainberg
Journal:  Clin Vaccine Immunol       Date:  2009-09-23

6.  Duodenal biopsy may be avoided when high transglutaminase antibody titers are present.

Authors:  Santiago Vivas; Jose G Ruiz de Morales; Sabino Riestra; Laura Arias; Dolores Fuentes; Noemi Alvarez; Sara Calleja; Mercedes Hernando; Blanca Herrero; Javier Casqueiro; Luis Rodrigo
Journal:  World J Gastroenterol       Date:  2009-10-14       Impact factor: 5.742

7.  Celiac disease in native Indians from Brazil: A clinical and epidemiological survey.

Authors:  Shirley Ramos da Rosa Utiyama; João Luis Coelho Ribas; Renato Mitsunori Nisihara; Lorete Maria da Silva Kotze; Iara José de Messias-Reason
Journal:  N Am J Med Sci       Date:  2010-03

8.  Trace gluten contamination may play a role in mucosal and clinical recovery in a subgroup of diet-adherent non-responsive celiac disease patients.

Authors:  Justin R Hollon; Pamela A Cureton; Margaret L Martin; Elaine L Leonard Puppa; Alessio Fasano
Journal:  BMC Gastroenterol       Date:  2013-02-28       Impact factor: 3.067

9.  Celiac disease risk varies between birth cohorts, generating hypotheses about causality: evidence from 36 years of population-based follow-up.

Authors:  Fredinah Namatovu; Olof Sandström; Cecilia Olsson; Marie Lindkvist; Anneli Ivarsson
Journal:  BMC Gastroenterol       Date:  2014-04-02       Impact factor: 3.067

10.  Prior Misdiagnosis of Celiac Disease Is Common Among Patients Referred to a Tertiary Care Center: A Prospective Cohort Study.

Authors:  Gianluca Ianiro; Stefano Bibbò; Giovanni Bruno; Riccardo Ricci; Vincenzo Arena; Antonio Gasbarrini; Giovanni Cammarota
Journal:  Clin Transl Gastroenterol       Date:  2016-01-28       Impact factor: 4.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.